<DOC>
	<DOCNO>NCT00291733</DOCNO>
	<brief_summary>Levodopa-induced dyskinesia associate irregular oscillatory discharge characteristic basal ganglion . From hand , LEV share different electrophysiologic profile antiepileptic , inhibit hyper-synchronization abnormal neuronal firing experimental model epilepsy . LEV also reduce levodopa-induced dyskinesia MPTP-lesioned macaque modulate `` prim phenomenon '' associate long-term change synaptic function lead dyskinesia PD . Study objective : - To evaluate effect levetiracetam ( LEV ) two dos ( 500 1000mg ) v placebo disable dyskinesia develop result long-term treatment levodopa , occur time maximal clinical improvement patient Parkinson 's disease ( PD ) . - To evaluate safety LEV patient PD antiparkinsonian medication .</brief_summary>
	<brief_title>Levetiracetam Administration Management Levodopa-Induced Dyskinesias Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosis PD accord criterion United Kingdom Parkinson 's Disease Society Brain Bank . Other inclusion criterion : Patients age 30 80 Hoehn Yahr stage PD IIb Levodopainduced dyskinesia ( LID ) despite optimization antiparkinsonian medication LID severity 2 item 32 duration 2 item 33 Unified Parkinson 's Disease Rating Scale ( UPDRS ) part IV Patient willing adhere protocol requirement evidence write informed consent Patient history medical condition clinically significant laboratory abnormality subject unwarranted risk . Female patient pregnant breastfeed use continue use adequate contraceptive method last 30 day , least one year postmenopausal . Patient ablative surgery DBS implantation electrodes disease basal ganglion . Patient low Minimental Examination MMSE score &lt; 25 history bipolar psychosis schizophrenia . Patient unwilling sign inform consent comply protocol requirement . Patient take take past month amantadine .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Levodopa-induced dyskinesia</keyword>
	<keyword>Parkinson 's</keyword>
</DOC>